Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinal Neoplasms | 13 | 2019 | 147 | 3.100 |
Why?
|
Retinoblastoma | 16 | 2017 | 316 | 2.750 |
Why?
|
Retinal Diseases | 12 | 2022 | 709 | 2.110 |
Why?
|
Vitreoretinopathy, Proliferative | 11 | 2017 | 75 | 1.350 |
Why?
|
Retinal Detachment | 10 | 2024 | 426 | 1.220 |
Why?
|
Eye Abnormalities | 3 | 2021 | 243 | 1.120 |
Why?
|
Retinopathy of Prematurity | 5 | 2022 | 449 | 0.940 |
Why?
|
Vitrectomy | 7 | 2019 | 389 | 0.940 |
Why?
|
Retina | 9 | 2022 | 2657 | 0.910 |
Why?
|
Photography | 4 | 2020 | 533 | 0.860 |
Why?
|
Triamcinolone Acetonide | 1 | 2023 | 105 | 0.790 |
Why?
|
Fluorescein Angiography | 10 | 2024 | 1085 | 0.780 |
Why?
|
Hemangioma | 3 | 2022 | 723 | 0.730 |
Why?
|
Vitreous Hemorrhage | 2 | 2015 | 47 | 0.730 |
Why?
|
Ocular Hypotension | 1 | 2021 | 23 | 0.720 |
Why?
|
Choroid | 4 | 2014 | 363 | 0.690 |
Why?
|
Retinal Vessels | 4 | 2021 | 863 | 0.690 |
Why?
|
Eye Enucleation | 2 | 2017 | 128 | 0.660 |
Why?
|
Visual Acuity | 13 | 2024 | 2708 | 0.640 |
Why?
|
Acyltransferases | 1 | 2021 | 305 | 0.630 |
Why?
|
Sturge-Weber Syndrome | 2 | 2022 | 88 | 0.570 |
Why?
|
Choroid Neoplasms | 2 | 2022 | 175 | 0.570 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2020 | 252 | 0.560 |
Why?
|
Retinal Perforations | 4 | 2019 | 138 | 0.520 |
Why?
|
Telomere-Binding Proteins | 1 | 2017 | 122 | 0.510 |
Why?
|
Uveal Neoplasms | 3 | 2014 | 343 | 0.500 |
Why?
|
Cataract | 3 | 2016 | 837 | 0.500 |
Why?
|
Choroidal Neovascularization | 3 | 2024 | 360 | 0.490 |
Why?
|
Vitreous Body | 8 | 2017 | 400 | 0.490 |
Why?
|
Ciliary Body | 2 | 2021 | 168 | 0.480 |
Why?
|
Twins, Monozygotic | 1 | 2017 | 469 | 0.480 |
Why?
|
Diseases in Twins | 1 | 2017 | 448 | 0.470 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 2015 | 59 | 0.470 |
Why?
|
Retinal Hemorrhage | 2 | 2015 | 98 | 0.460 |
Why?
|
Retinal Pigment Epithelium | 3 | 2017 | 310 | 0.460 |
Why?
|
Retinoschisis | 2 | 2016 | 30 | 0.460 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 7 | 2015 | 368 | 0.450 |
Why?
|
Hydrophthalmos | 1 | 2014 | 24 | 0.450 |
Why?
|
Ophthalmic Artery | 1 | 2014 | 56 | 0.440 |
Why?
|
Retinoblastoma Protein | 5 | 2012 | 666 | 0.430 |
Why?
|
Abnormalities, Multiple | 1 | 2021 | 1424 | 0.430 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2017 | 354 | 0.430 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2014 | 135 | 0.430 |
Why?
|
Bone Diseases, Metabolic | 1 | 2017 | 407 | 0.420 |
Why?
|
Ischemia | 1 | 2021 | 1909 | 0.390 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2022 | 3513 | 0.390 |
Why?
|
Femoral Fractures | 1 | 2015 | 375 | 0.360 |
Why?
|
Lymphoma | 2 | 2013 | 1897 | 0.360 |
Why?
|
Blindness | 3 | 2013 | 586 | 0.330 |
Why?
|
Retinal Telangiectasis | 2 | 2019 | 26 | 0.310 |
Why?
|
Retinal Neovascularization | 2 | 2024 | 289 | 0.310 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2741 | 0.310 |
Why?
|
von Hippel-Lindau Disease | 2 | 2020 | 154 | 0.300 |
Why?
|
Choroid Diseases | 1 | 2009 | 63 | 0.300 |
Why?
|
Macular Degeneration | 2 | 2022 | 1014 | 0.290 |
Why?
|
Laser Therapy | 1 | 2015 | 1108 | 0.290 |
Why?
|
Angiogenesis Inhibitors | 3 | 2024 | 2056 | 0.290 |
Why?
|
Eye Injuries, Penetrating | 1 | 2009 | 121 | 0.270 |
Why?
|
Eye Neoplasms | 2 | 2006 | 304 | 0.270 |
Why?
|
Eye Diseases | 3 | 2019 | 659 | 0.270 |
Why?
|
Bone Marrow | 1 | 2017 | 2921 | 0.270 |
Why?
|
Glaucoma, Neovascular | 1 | 2006 | 37 | 0.270 |
Why?
|
Mutation | 8 | 2021 | 30198 | 0.260 |
Why?
|
Corneal Diseases | 2 | 2022 | 535 | 0.250 |
Why?
|
Ophthalmology | 1 | 2012 | 561 | 0.250 |
Why?
|
Child Abuse | 1 | 2015 | 1090 | 0.250 |
Why?
|
Tomography, Optical Coherence | 7 | 2024 | 2932 | 0.250 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2008 | 640 | 0.250 |
Why?
|
Calcinosis | 1 | 2014 | 1479 | 0.250 |
Why?
|
Epilepsy | 1 | 2021 | 3320 | 0.240 |
Why?
|
Genes, Retinoblastoma | 3 | 2012 | 125 | 0.240 |
Why?
|
Infant | 14 | 2022 | 36386 | 0.230 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2008 | 568 | 0.230 |
Why?
|
Aqueous Humor | 1 | 2024 | 152 | 0.220 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2007 | 385 | 0.220 |
Why?
|
Wnt Proteins | 1 | 2007 | 722 | 0.210 |
Why?
|
Deafness | 1 | 2007 | 460 | 0.210 |
Why?
|
Centrifugation | 1 | 2023 | 121 | 0.210 |
Why?
|
Incontinentia Pigmenti | 1 | 2022 | 12 | 0.200 |
Why?
|
Fundus Oculi | 5 | 2024 | 559 | 0.190 |
Why?
|
Turner Syndrome | 1 | 2022 | 129 | 0.180 |
Why?
|
Humans | 66 | 2024 | 765968 | 0.180 |
Why?
|
Eye Injuries | 3 | 2016 | 228 | 0.180 |
Why?
|
Retinitis Pigmentosa | 1 | 2024 | 394 | 0.180 |
Why?
|
Term Birth | 1 | 2021 | 140 | 0.170 |
Why?
|
Hemangioblastoma | 1 | 2019 | 63 | 0.160 |
Why?
|
Alcohol Oxidoreductases | 1 | 2020 | 164 | 0.160 |
Why?
|
Endotamponade | 1 | 2019 | 37 | 0.160 |
Why?
|
Epiretinal Membrane | 1 | 2019 | 72 | 0.150 |
Why?
|
Central Nervous System Diseases | 1 | 2022 | 518 | 0.140 |
Why?
|
Exudates and Transudates | 2 | 2008 | 173 | 0.140 |
Why?
|
Cornea | 2 | 2022 | 1316 | 0.140 |
Why?
|
Anophthalmos | 1 | 2017 | 23 | 0.140 |
Why?
|
Biopsy | 1 | 2009 | 6763 | 0.140 |
Why?
|
Gestational Age | 2 | 2017 | 3609 | 0.130 |
Why?
|
Vitreoretinal Surgery | 1 | 2016 | 28 | 0.130 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 660 | 0.130 |
Why?
|
Retrospective Studies | 22 | 2024 | 81514 | 0.130 |
Why?
|
Amyloidosis | 1 | 2004 | 885 | 0.130 |
Why?
|
Rabbits | 7 | 2017 | 4734 | 0.130 |
Why?
|
Scleral Buckling | 1 | 2016 | 94 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2014 | 1657 | 0.120 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 904 | 0.120 |
Why?
|
Intravitreal Injections | 3 | 2024 | 401 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2017 | 360 | 0.120 |
Why?
|
p120 GTPase Activating Protein | 1 | 2015 | 35 | 0.120 |
Why?
|
Signal Transduction | 10 | 2020 | 23601 | 0.120 |
Why?
|
Telemedicine | 1 | 2012 | 3105 | 0.120 |
Why?
|
Child, Preschool | 12 | 2020 | 42500 | 0.120 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2015 | 83 | 0.120 |
Why?
|
Cytokines | 2 | 2024 | 7421 | 0.110 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2015 | 182 | 0.110 |
Why?
|
Coloboma | 1 | 2014 | 60 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 548 | 0.110 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 182 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 434 | 0.110 |
Why?
|
S100 Proteins | 1 | 2014 | 217 | 0.110 |
Why?
|
Pupil Disorders | 1 | 2013 | 33 | 0.110 |
Why?
|
Cell Proliferation | 7 | 2020 | 10429 | 0.110 |
Why?
|
Child | 17 | 2024 | 80564 | 0.110 |
Why?
|
Keratins | 1 | 2014 | 498 | 0.100 |
Why?
|
Glaucoma | 1 | 2022 | 1194 | 0.100 |
Why?
|
Color | 1 | 2013 | 299 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 6069 | 0.100 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 564 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2020 | 2453 | 0.100 |
Why?
|
Cataract Extraction | 1 | 2016 | 464 | 0.100 |
Why?
|
ADP-Ribosylation Factors | 1 | 2012 | 130 | 0.090 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1701 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 2 | 2022 | 3737 | 0.090 |
Why?
|
Female | 29 | 2024 | 396112 | 0.090 |
Why?
|
Diabetic Retinopathy | 1 | 2020 | 1299 | 0.090 |
Why?
|
Ultrasonography | 2 | 2014 | 5993 | 0.090 |
Why?
|
Radiotherapy, High-Energy | 1 | 2010 | 226 | 0.080 |
Why?
|
Eye Proteins | 1 | 2013 | 628 | 0.080 |
Why?
|
Mucin-1 | 1 | 2014 | 531 | 0.080 |
Why?
|
Endothelial Cells | 2 | 2020 | 3584 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2013 | 540 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2014 | 1831 | 0.080 |
Why?
|
Fovea Centralis | 1 | 2010 | 126 | 0.080 |
Why?
|
Male | 24 | 2024 | 363698 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2017 | 2942 | 0.080 |
Why?
|
Optic Nerve Neoplasms | 1 | 2009 | 45 | 0.080 |
Why?
|
Prognosis | 7 | 2020 | 29922 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 684 | 0.070 |
Why?
|
Pericytes | 1 | 2010 | 299 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2022 | 26346 | 0.070 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2140 | 0.070 |
Why?
|
Disease Models, Animal | 4 | 2017 | 18293 | 0.070 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39193 | 0.070 |
Why?
|
Nevus, Pigmented | 1 | 2009 | 227 | 0.070 |
Why?
|
Leukemia L5178 | 1 | 2005 | 14 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1050 | 0.060 |
Why?
|
Phenotype | 2 | 2022 | 16721 | 0.060 |
Why?
|
Adolescent | 11 | 2020 | 88835 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2428 | 0.060 |
Why?
|
Prostheses and Implants | 2 | 2022 | 1273 | 0.060 |
Why?
|
Trans-Activators | 1 | 2014 | 2850 | 0.060 |
Why?
|
Molecular Biology | 1 | 2007 | 574 | 0.050 |
Why?
|
Cells, Cultured | 6 | 2017 | 18973 | 0.050 |
Why?
|
HMGA2 Protein | 1 | 2003 | 101 | 0.050 |
Why?
|
Protons | 2 | 2022 | 1073 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 11888 | 0.050 |
Why?
|
Retinoblastoma-Like Protein p107 | 2 | 2012 | 70 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4392 | 0.050 |
Why?
|
Prealbumin | 1 | 2004 | 266 | 0.050 |
Why?
|
Cell Movement | 3 | 2020 | 5194 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 995 | 0.050 |
Why?
|
Chemokines | 1 | 2024 | 956 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2002 | 475 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2631 | 0.040 |
Why?
|
Blotting, Western | 2 | 2017 | 5020 | 0.040 |
Why?
|
Animals | 14 | 2020 | 168764 | 0.040 |
Why?
|
X Chromosome | 1 | 2022 | 819 | 0.040 |
Why?
|
Adult | 12 | 2024 | 223044 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2966 | 0.040 |
Why?
|
Mice | 10 | 2020 | 81819 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9373 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18071 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 16047 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2022 | 595 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2020 | 594 | 0.040 |
Why?
|
Fibroblasts | 2 | 2012 | 4159 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36532 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2020 | 680 | 0.030 |
Why?
|
Persistent Hyperplastic Primary Vitreous | 1 | 2016 | 7 | 0.030 |
Why?
|
Mice, Knockout | 4 | 2016 | 14448 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2003 | 1727 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 4893 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 2017 | 228 | 0.030 |
Why?
|
Young Adult | 6 | 2020 | 59889 | 0.030 |
Why?
|
Pedigree | 2 | 2020 | 4526 | 0.030 |
Why?
|
Time Factors | 4 | 2019 | 40065 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3785 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1740 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 22223 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3690 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2006 | 8529 | 0.030 |
Why?
|
Streptococcus pyogenes | 1 | 2017 | 295 | 0.030 |
Why?
|
Probability | 1 | 2019 | 2475 | 0.030 |
Why?
|
Apoptosis | 3 | 2017 | 9514 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12976 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1823 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2005 | 3081 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15543 | 0.030 |
Why?
|
Aged | 7 | 2024 | 171117 | 0.020 |
Why?
|
Middle Aged | 8 | 2024 | 223009 | 0.020 |
Why?
|
Melanoma | 1 | 2010 | 5719 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1599 | 0.020 |
Why?
|
Stents | 1 | 2003 | 3213 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2020 | 11022 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2013 | 735 | 0.020 |
Why?
|
Cell Survival | 2 | 2016 | 5747 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3797 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 476 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2013 | 615 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1007 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 587 | 0.020 |
Why?
|
Genetic Loci | 1 | 2020 | 2631 | 0.020 |
Why?
|
Cell Division | 2 | 2011 | 4475 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 372 | 0.020 |
Why?
|
Brain | 1 | 2017 | 27171 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2012 | 663 | 0.020 |
Why?
|
Immunotherapy | 1 | 2005 | 4752 | 0.020 |
Why?
|
Macrophages | 2 | 2020 | 5772 | 0.020 |
Why?
|
Conjunctiva | 1 | 2012 | 477 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 703 | 0.020 |
Why?
|
Platelet-Rich Plasma | 1 | 2011 | 179 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6897 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 698 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2011 | 462 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21480 | 0.020 |
Why?
|
Multigene Family | 1 | 2011 | 1080 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2013 | 959 | 0.020 |
Why?
|
Glucose | 1 | 2020 | 4335 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1495 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2014 | 2865 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13632 | 0.020 |
Why?
|
Base Sequence | 2 | 2012 | 12403 | 0.020 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2007 | 72 | 0.020 |
Why?
|
Autophagy | 1 | 2015 | 1351 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41649 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2005 | 6113 | 0.020 |
Why?
|
Imidazoles | 1 | 2012 | 1162 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2007 | 772 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2013 | 1789 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 65188 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 2669 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59489 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2007 | 572 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 1643 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4260 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2007 | 1546 | 0.010 |
Why?
|
Prevalence | 1 | 2022 | 15842 | 0.010 |
Why?
|
Anesthesia | 1 | 2016 | 1590 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2016 | 5302 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2005 | 214 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 4427 | 0.010 |
Why?
|
Anterior Chamber | 1 | 2005 | 194 | 0.010 |
Why?
|
Rupture | 1 | 2006 | 443 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2005 | 425 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 2005 | 623 | 0.010 |
Why?
|
Collagen | 1 | 2012 | 2618 | 0.010 |
Why?
|
Laser Coagulation | 1 | 2006 | 334 | 0.010 |
Why?
|
HMGA1b Protein | 1 | 2003 | 1 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6919 | 0.010 |
Why?
|
HMGA1a Protein | 1 | 2003 | 63 | 0.010 |
Why?
|
RNA, Antisense | 1 | 2003 | 135 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8923 | 0.010 |
Why?
|
Cobalt Radioisotopes | 1 | 2002 | 75 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12768 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2003 | 11499 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2005 | 919 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2844 | 0.010 |
Why?
|
Keratitis | 1 | 2005 | 239 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6493 | 0.010 |
Why?
|
Piperazines | 1 | 2012 | 2549 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2005 | 1347 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2005 | 2014 | 0.010 |
Why?
|
G1 Phase | 1 | 2002 | 403 | 0.010 |
Why?
|
Gamma Rays | 1 | 2002 | 324 | 0.010 |
Why?
|
Photochemotherapy | 1 | 2006 | 826 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1966 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9550 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7584 | 0.010 |
Why?
|
Clone Cells | 1 | 2002 | 1672 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14652 | 0.010 |
Why?
|
Ligands | 1 | 2005 | 3273 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14751 | 0.010 |
Why?
|
Mice, Nude | 1 | 2003 | 3618 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12795 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9443 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3634 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20124 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9525 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 17075 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74840 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 14071 | 0.010 |
Why?
|
Neutrophils | 1 | 2005 | 3776 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5786 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 17594 | 0.010 |
Why?
|
Pregnancy | 1 | 2011 | 30260 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2005 | 4353 | 0.010 |
Why?
|
Skin | 1 | 2002 | 4489 | 0.000 |
Why?
|